Heather Renee Ibach, LAC, LSW | |
1237 W Divide Ave, Ste 5, Bismarck, ND 58501-1208 | |
(701) 328-8888 | |
(701) 328-8900 |
Full Name | Heather Renee Ibach |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 1237 W Divide Ave, Bismarck, North Dakota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972829950 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 1622 (North Dakota) | Primary |
104100000X | Social Worker | 4272 (North Dakota) | Secondary |
Entity Name | West Central Human Service Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649226713 PECOS PAC ID: 6002801107 Enrollment ID: O20040419000160 |
News Archive
A study by researchers at the George Washington University School of Public Health and Health Services indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer.
With a large percentage of women in the workplace aged between 40 and 59 years, the challenge of women managing menopause symptoms while at work is commonplace.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
The Food and Drug Administration has announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.
› Verified 2 days ago
Entity Name | Beacon Counseling Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073110383 PECOS PAC ID: 5597141044 Enrollment ID: O20221212003174 |
News Archive
A study by researchers at the George Washington University School of Public Health and Health Services indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer.
With a large percentage of women in the workplace aged between 40 and 59 years, the challenge of women managing menopause symptoms while at work is commonplace.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
The Food and Drug Administration has announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Heather Renee Ibach, LAC, LSW 1237 W Divide Ave, Ste 5, Bismarck, ND 58501-1208 Ph: (701) 328-8888 | Heather Renee Ibach, LAC, LSW 1237 W Divide Ave, Ste 5, Bismarck, ND 58501-1208 Ph: (701) 328-8888 |
News Archive
A study by researchers at the George Washington University School of Public Health and Health Services indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer.
With a large percentage of women in the workplace aged between 40 and 59 years, the challenge of women managing menopause symptoms while at work is commonplace.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
The Food and Drug Administration has announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.
› Verified 2 days ago
Victoria Ngatia, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1720 Burnt Boat Dr Ste 104, Bismarck, ND 58503 Phone: 701-751-1006 | |
Sandra Bender, Counselor Medicare: Medicare Enrolled Practice Location: 1800 E Interstate Ave, Bismarck, ND 58503 Phone: 701-323-8800 | |
Sue A Mock, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1237 W Divide Ave, Ste 5, Bismarck, ND 58501 Phone: 701-328-8763 Fax: 701-328-8900 | |
Tara Moszer, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1237 W Divide Ave, Ste 5, Bismarck, ND 58501 Phone: 701-328-8888 Fax: 701-328-8900 | |
Julie Ann Aman, OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 311 N 11th St, Bismarck, ND 58501 Phone: 701-530-7256 Fax: 701-530-7257 | |
Mrs. Patricia Mary Hulm, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 S 2nd St, Suite 201, Bismarck, ND 58504 Phone: 701-258-3780 Fax: 701-751-1328 | |
Patrick L Joyce, LAPC Counselor Medicare: Medicare Enrolled Practice Location: 1237 W Divide Ave Ste 5, Bismarck, ND 58501 Phone: 701-328-8888 |